Abstract

Serono, third largest biotech company, focuses on the discovery, development and marketing of recombinant proteins and small molecules in the fields of reproductive health for treating infertility, neurology for treating relapse of multiple sclerosis, metabolic endocrinology for treating HIV-associated wasting and growth deficiencies, autoimmune diseases, oncology, gastroenterology and rheumatology...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login on the top right purple box.

Copyright: PharmaVentures Ltd